A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the dose of aflibercept to be further
studied in combination with docetaxel in Japanese cancer patients.
The secondary objectives of this study are to assess the safety profile of aflibercept, to
determine the pharmacokinetics of aflibercept, to make a preliminary assessment of antitumor
effects.